Overview

Modern Meadow creates sustainable biomaterials for various industries through biofabrication. Their products are based on two main platforms: Bio-Alloy™ and Bio-F@rm™. Bio-Alloy™ combines proteins with biobased polymers to produce materials that are more efficient than traditional options, allowing partners to manufacture at scale while saving resources. Bio-F@rm™ focuses on engineering fermentation-based proteins for applications in beauty and wellness. By collaborating with companies, Modern Meadow helps them develop high-quality, sustainable products without relying on animal or virgin petro inputs, thus reducing their environmental impact. Their goal is to lead in biofabrication by providing effective solutions that promote sustainability across different sectors.

Simplify's Take

What believers are saying

• Growing demand for sustainable fashion boosts Modern Meadow's biomaterials market.
• EU's Green Deal increases demand for sustainable production, benefiting Modern Meadow.
• Collaborations with fashion brands integrate biomaterials into mainstream fashion.

What critics are saying

• Increased competition in biofabrication threatens Modern Meadow's market share.
• Consumer skepticism towards alternative proteins may impact Modern Meadow's growth.
• Rapid tech advancements require costly R&D to maintain competitive edge.

What makes Modern Meadow unique

• Modern Meadow's Bio-Alloy™ platform creates superior materials outperforming traditional ones.
• Bio-F@rm™ enables large-scale production of fermentation-based proteins for diverse applications.
• Partnerships with brands like Bellroy and MAES Paris highlight their industry influence.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$186.1M

Above

Industry Average

Funded Over

5 Rounds

$130,000,000

Series C

Apr 2021

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Above Average

Industry standards

Ind Avg. $50M

$16M

$40M

$50M

$62M

$100M

$130M

View all funding stages